Qishen Granule (QSG) Inhibits Monocytes Released From the Spleen and Protect Myocardial Function via the TLR4-MyD88-NF-κB p65 Pathway in Heart Failure Mice

• Main Authors: Yanqin Li (Author), Xuan Li (Author), Xu Chen (Author), Xiaoqian Sun (Author), Xiangning Liu (Author), Gang Wang (Author), Yizhou Liu (Author), Lingwen Cui (Author), Tianhua Liu (Author), Wei Wang (Author), Yong Wang (Author), Chun Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Preliminary clinical and basic researches have proved that Qishen granule (QSG) is an effective prescription for treating heart failure (HF) in China, with a characteristic of regulating the ratio of M1/M2 macrophage in the myocardium. However, the regulative mechanism of monocytes targeting the car...